Aktuelle Studien

 

Eigene Forschungsprojekte

COVIVA: COronaVIrus survival: Diverse Forschungsfragen zu COVID-19 werden von mehreren Forschungsgruppen des Hauses erforscht und das gesamte Projekt von Raphael Twerenbold, Kardiologie koordiniert.

Unsere Forschungsfragen: 

  • D-dimer for Risk Stratification in Patients with Suspected COVID-19 – A Prospective Observational Study
  • Association of Frailty with Adverse Outcomes in Patients with Suspected COVID-19 Infection
  • Negative X-Ray of pelvis followed by CT examination – frequency of surgical treatment in CT- detected fractures of the pelvis
  • COVID-19 mimics and chameleons
  • Disparities in emergency department access, resource allocation, and outcomes between migrants and the local population
  • Association between Frailty and Nonspecific Complaints in Emergency Medicine
  • Risikostratifizierung und Evaluierung von Risikofaktoren hinsichtlich der Mortalität von Notfallpatienten
 

Multizenterstudien

OVID Studie:
Enoxaparin for primary Thromboprophylaxis in Ambulatory Patients with Coronavirus: the Multicenter Randomized Controlled OVID Trial
Link: https://medicalforum.ch/de/detail/doi/smf.2020.08566
https://new.usz.ch/studie/ovid-studie/

 

SAFE-SSPE Studie:
Clinical Surveillance vs. Anticoagulation for Low-risk Patients with Isolated Subsegmental Pulmonary Embolism: A Multicenter Randomized Placebo-Controlled Non-Inferiority Trial
Link: https://www.safesspe.ch/about-safe-sspe/information-about-the-study/

 

PROFUNDUS:
Integration of pre-test PRObability, Focused cardiac UltrasouNd and D-dimer for diagnosis of acUte aortic Syndromes (PROFUNDUS trial)

 

Wichtige Publikationen